Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 1,095,580 | N/A | N/A | N/A |
| Depreciation Amortization | N/A | 2,157,430 | N/A | N/A | N/A |
| Other Working Capital | N/A | -124,820 | N/A | N/A | N/A |
| Other Operating Activity | 0 | -1,644,840 | 0 | 0 | 0 |
| Operating Cash Flow | $N/A | $1,483,350 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -367,420 | N/A | N/A | N/A |
| Net Acquisitions | N/A | -33,420 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -1,185,270 | 0 | 0 | 0 |
| Investing Cash Flow | $N/A | $-1,586,110 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | N/A | -1,421,330 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 2,435,740 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $1,014,410 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | N/A | 293,030 | N/A | N/A | N/A |
| Beginning Cash Position | N/A | 5,455,800 | N/A | N/A | N/A |
| End Cash Position | N/A | 6,660,480 | N/A | N/A | N/A |
| Net Cash Flow | $N/A | $1,204,670 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 1,483,350 | N/A | N/A | N/A |
| Free Cash Flow | 0 | 1,483,350 | 0 | 0 | 0 |